These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 27934611)
21. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. Meredith Am IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Allocco DJ; Dawkins KD J Am Coll Cardiol; 2014 Sep; 64(13):1339-48. PubMed ID: 25257635 [TBL] [Abstract][Full Text] [Related]
22. Transaortic valve implantation with the direct flow medical valve in an emergency situation of post-valvuloplasty severe aortic regurgitation. Fuertes Ferre G; Latib A; Maisano F; Naganuma T; Alfieri O; Colombo A Cardiovasc Revasc Med; 2015; 16(5):317-9. PubMed ID: 25582986 [TBL] [Abstract][Full Text] [Related]
23. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement. Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463 [TBL] [Abstract][Full Text] [Related]
24. Transfemoral Implantation of a Fully Repositionable and Retrievable Transcatheter Valve for Noncalcified Pure Aortic Regurgitation. Schofer J; Nietlispach F; Bijuklic K; Colombo A; Gatto F; De Marco F; Mangieri A; Hansen L; Bruschi G; Ruparelia N; Rieß FC; Maisano F; Latib A JACC Cardiovasc Interv; 2015 Dec; 8(14):1842-9. PubMed ID: 26604062 [TBL] [Abstract][Full Text] [Related]
25. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eltchaninoff H; Prat A; Gilard M; Leguerrier A; Blanchard D; Fournial G; Iung B; Donzeau-Gouge P; Tribouilloy C; Debrux JL; Pavie A; Gueret P; Eur Heart J; 2011 Jan; 32(2):191-7. PubMed ID: 20843959 [TBL] [Abstract][Full Text] [Related]
26. Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices. Seiffert M; Fujita B; Avanesov M; Lunau C; Schön G; Conradi L; Prashovikj E; Scholtz S; Börgermann J; Scholtz W; Schäfer U; Lund G; Ensminger S; Treede H Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):576-84. PubMed ID: 26160399 [TBL] [Abstract][Full Text] [Related]
27. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437 [TBL] [Abstract][Full Text] [Related]
28. Impact and natural history of postprocedural aortic regurgitation on early and midterm mortality following transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. Ielasi A; Latib A; Sacco FM; Costopoulos C; Figini F; Grimaldi A; Naim C; Maisano F; Chieffo A; Montorfano M; Alfieri O; Colombo A J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):286-95. PubMed ID: 25643194 [TBL] [Abstract][Full Text] [Related]